1-Bromo-3,4,5-trimethoxybenzene(cas: 2675-79-8) is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff.Electric Literature of C9H11BrO31-Bromo-3,4,5-trimethoxybenzene can be used to synthesize analogs of HA14-1, which shows promising anticancer properties.
Electric Literature of C9H11BrO3In 2021 ,《Synthesis and biological evaluation of 1-(diarylmethyl)-1H-1,2,4-triazoles and 1-(diarylmethyl)-1H-imidazoles as a novel class of anti-mitotic agent for activity in breast cancer》 appeared in Pharmaceuticals. The author of the article were Ana, Gloria; Kelly, Patrick M.; Malebari, Azizah M.; Noorani, Sara; Nathwani, Seema M.; Twamley, Brendan; Fayne, Darren; O’Boyle, Niamh M.; Zisterer, Daniela M.; Pimentel, Elisangela Flavia; Endringer, Denise Coutinho; Meegan, Mary J.. The article conveys some information:
Synthesis and biochem. evaluation of diaryl(heterocyclyl)methanes R1CH(X)R2 (I) [X = 1,2,4-triazol-1-yl, 1-imidazolyl, 1-pyrrolidinyl, 1-piperidinyl, N-R3-piperazin-1-yl, 1,2,3-triazol-2-yl; R1, R2 = Ph, 4-HOC6H4, 3-HO-4-MeOC6H3, 3,4,5-(MeO)3C6H2, etc.; R3 = H, Ph, PhCH2, etc.], that were designed as hybrids of the microtubule targeting benzophenone phenstatin and the aromatase inhibitor letrozole, are described. A preliminary screening in estrogen receptor (ER)-pos. MCF-7 breast cancer cells identified the compound I [X = 1,2,3-triazol-2-yl; R1 = 3,4,5-(MeO)3C6H2; R2 = 3-HO-4-MeOC6H3] as a potent antiproliferative compound with an IC50 value of 52 nM in MCF-7 breast cancer cells (ER+/PR+) and 74 nM in triple-neg. MDA-MB-231 breast cancer cells. The compounds I demonstrated significant G2/M phase cell cycle arrest and induction of apoptosis in the MCF-7 cell line, inhibited tubulin polymerization, and were selective for cancer cells when evaluated in non-tumorigenic MCF-10A breast cells. The immunofluorescence staining of MCF-7 cells confirmed that these compounds targeted tubulin and induced multinucleation, which was a recognized sign of mitotic catastrophe. Computational docking studies of compounds I [X = 1,2,4-triazol-1-yl, imidazol-1-yl, 1,2,3-triazol-2-yl; R1 = 3,4,5-(MeO)3C6H2; R2 = 3-OH-4-MeOC6H3] in the colchicine binding site of tubulin indicated potential binding conformations for the compounds The compounds I [X = 1,2,4-triazol-1-yl, imidazol-1-yl; R1 = 3,4,5-(MeO)3C6H2; R2 = 3-OH-4-MeOC6H3] were also shown to selectively inhibit aromatase. These compounds are promising candidates for development as antiproliferative, aromatase inhibitory, and microtubule-disrupting agents for breast cancer. The experimental process involved the reaction of 1-Bromo-3,4,5-trimethoxybenzene(cas: 2675-79-8Electric Literature of C9H11BrO3)
1-Bromo-3,4,5-trimethoxybenzene(cas: 2675-79-8) is an important raw material and intermediate used in organic synthesis, pharmaceuticals, agrochemicals and dyestuff.Electric Literature of C9H11BrO31-Bromo-3,4,5-trimethoxybenzene can be used to synthesize analogs of HA14-1, which shows promising anticancer properties.
Referemce:
Bromide – Wikipedia,
bromide – Wiktionary